Resultados de la búsqueda 1851-1860 of 10583 for Epilepsy (Partial Onset)

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. ... Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps.

  3. Oncología (médica) - Ensayos clínicos

    The objectives of this study are to genomically characterize patient-derived organoids (PDOs) and primary tissues from colorectal peritoneal cancer (CRC) ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to combine robust clinical data (e.g., prior chemotherapy or radiation exposure, cumulative Peptide Receptor Radionuclide ...

  5. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to discover and validate DNA methylation-based markers that identify patients with metastatic melanoma based on the detection ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to answer whether plasma circulating tumor DNA (ctDNA) obtained by serial analysis before, during, and following surgery, ...

  8. Oncología (médica) - Ensayos clínicos

    Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, ...

  9. Oncología (médica) - Ensayos clínicos

    This study will collect and store samples of tissue and blood for current and future research studies on Liver and Biliary Tumors. A Study to Evaluate Immune ...

  10. Oncología (médica) - Ensayos clínicos

    The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...